Stem Cells Within Three-Dimensional-Printed Scaffolds Facilitate Airway Mucosa and Bone Regeneration and Reconstruction of Maxillary Defects in Rabbits DOI Creative Commons

Mi Hyun Lim,

Jung Ho Jeon,

Sun Hwa Park

et al.

Medicina, Journal Year: 2024, Volume and Issue: 60(12), P. 2111 - 2111

Published: Dec. 23, 2024

Background and Objectives: Current craniofacial reconstruction surgical methods have limitations because they involve facial deformation. The region includes many areas where the mucosa, exposed to air, is closely adjacent bone, with maxilla being a prominent example of this structure. Therefore, study explored whether human neural-crest-derived stem cells (hNTSCs) aid bone airway mucosal regeneration during using rabbit model. Materials Methods: hNTSCs were induced differentiate into either epithelial or osteogenic in vitro. seeded polycaprolactone scaffold (three-dimensionally printed) that implanted rabbits maxillary defects. Four weeks later, tissue was analyzed via histological evaluation immunofluorescence staining. Results: In vitro, differentiated both cells. hNTSC differentiation respiratory confirmed by Alcian Blue staining, cilia SEM, increased expression levels FOXJ1 E-cadherin through quantitative RT-PCR. Alizarin Red mRNA BMP2 (6.1-fold) RUNX2 (2.3-fold) group compared control. post-transplantation, harvested, H&E, immunohistofluorescence staining performed. H&E SEM showed new around defect more group. Also, positive for acetylated α-tubulin cytokerin-5 control Conclusions: combined PCL enhanced vitro promoted vivo

Language: Английский

Regenerative Medicine in Plastic Surgery: The Role of Stem Cells and Bioprinting DOI Creative Commons
Kirolos Eskandar

Regenesis repair rehabilitation., Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Language: Английский

Citations

0

Development of Biomimetic Substrates for Limbal Epithelial Stem Cells Using Collagen-Based Films, Hyaluronic Acid, Immortalized Cells, and Macromolecular Crowding DOI Creative Commons
Mehmet Gürdal, Gülinnaz Ercan, Özlem Barut Selver

et al.

Life, Journal Year: 2024, Volume and Issue: 14(12), P. 1552 - 1552

Published: Nov. 26, 2024

Despite the promising potential of cell-based therapies developed using tissue engineering techniques to treat a wide range diseases, including limbal stem cell deficiency (LSCD), which leads corneal blindness, their commercialization remains constrained. This is primarily attributable limited sources, use non-standardizable, unscalable, and unsustainable techniques, extended manufacturing processes required produce transplantable tissue-like surrogates. Herein, we present first demonstration novel approach combining collagen films (CF), hyaluronic acid (HA), human telomerase-immortalized epithelial cells (T-LESCs), macromolecular crowding (MMC) develop innovative biomimetic substrates for (LESCs). The initial step involved fabrication characterization CF enriched with HA (CF-HA). Subsequently, T-LESCs were seeded on CF, CF-HA, culture plastic (TCP). Thereafter, effect these matrices basic cellular function tissue-specific extracellular matrix (ECM) deposition or without MMC was evaluated. viability metabolic activity cultured TCP found be similar, while CF-HA induced highest (p < 0.05) proliferation. It notable that growth, whereas increased IV, fibronectin, laminin in T-LESC culture. data highlight of, particular, immortalized development substrates, could utilized ocular surface reconstruction following further vitro, vivo, clinical validation approach.

Language: Английский

Citations

1

From Bench to Bedside: Translating Cellular Rejuvenation Therapies into Clinical Applications DOI Creative Commons
Timur Saliev, Prim B. Singh

Cells, Journal Year: 2024, Volume and Issue: 13(24), P. 2052 - 2052

Published: Dec. 12, 2024

Cellular rejuvenation therapies represent a transformative frontier in addressing age-related decline and extending human health span. By targeting fundamental hallmarks of aging—such as genomic instability, epigenetic alterations, mitochondrial dysfunction, cellular senescence—these aim to restore youthful functionality cells tissues, offering new hope for treating degenerative diseases. Recent advancements have showcased range strategies, including reprogramming, senolytic interventions, restoration, stem cell-based approaches, gene-editing technologies like CRISPR. Each modality has demonstrated substantial potential preclinical models is now being cautiously explored early-stage clinical trials. However, translating these from the laboratory practice presents unique challenges: safety concerns, delivery precision, complex regulatory requirements, ethical considerations, high costs impede widespread adoption. This review examines current landscape rejuvenation, highlighting key advancements, risks, strategies needed overcome hurdles.

Language: Английский

Citations

1

Stem Cells Within Three-Dimensional-Printed Scaffolds Facilitate Airway Mucosa and Bone Regeneration and Reconstruction of Maxillary Defects in Rabbits DOI Creative Commons

Mi Hyun Lim,

Jung Ho Jeon,

Sun Hwa Park

et al.

Medicina, Journal Year: 2024, Volume and Issue: 60(12), P. 2111 - 2111

Published: Dec. 23, 2024

Background and Objectives: Current craniofacial reconstruction surgical methods have limitations because they involve facial deformation. The region includes many areas where the mucosa, exposed to air, is closely adjacent bone, with maxilla being a prominent example of this structure. Therefore, study explored whether human neural-crest-derived stem cells (hNTSCs) aid bone airway mucosal regeneration during using rabbit model. Materials Methods: hNTSCs were induced differentiate into either epithelial or osteogenic in vitro. seeded polycaprolactone scaffold (three-dimensionally printed) that implanted rabbits maxillary defects. Four weeks later, tissue was analyzed via histological evaluation immunofluorescence staining. Results: In vitro, differentiated both cells. hNTSC differentiation respiratory confirmed by Alcian Blue staining, cilia SEM, increased expression levels FOXJ1 E-cadherin through quantitative RT-PCR. Alizarin Red mRNA BMP2 (6.1-fold) RUNX2 (2.3-fold) group compared control. post-transplantation, harvested, H&E, immunohistofluorescence staining performed. H&E SEM showed new around defect more group. Also, positive for acetylated α-tubulin cytokerin-5 control Conclusions: combined PCL enhanced vitro promoted vivo

Language: Английский

Citations

0